Brief: FibroBiologics Advances Bone Marrow Organoid Tech for Cancer & Immune Therapies
10/09/2025 13:39
Sept 10 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS ANNOUNCES SIGNIFICANT ADVANCEMENTS IN BONE MARROW ORGANOID PLATFORM ENABLING DEVELOPMENT FOR CANCER AND IMMUNE-RELATED THERAPIES FIBROBIOLOGICS: BONE MARROW ORGANOIDS TRANSPLANTATION INTO MELANOMA MOUSE MODEL REDUCES TUMOR SIZE Source text: ID:nGNX7qNMdq Further company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts